Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Perrigo appointment

This article was originally published in The Tan Sheet

Executive Summary

Judy Brown, Senior VP and Corporate Controller for Perrigo, will assume her new role as the company's CFO and Chief Accounting Officer July 1, the Allegan, Mich.-based firm announces March 2. Brown will replace current CFO Douglas Schrank, who has been at Perrigo for six years. Brown is a certified public accountant who previously worked for Whirlpool and Ernst & Young. In her current role, Brown has helped lead the company through its acquisition of Agis Industries, which was completed in March (1"The Tan Sheet" Nov. 22, 2004, p. 6)...

You may also be interested in...



Perrigo Moves In On Major Generic Firms With Agis Acquisition

Perrigo's acquisition of Israeli generic drug firm Agis Pharmaceuticals will put the combined entity's annualized sales over the $1 bil. mark and in the same league with major Rx generic drug players

UK IVDs Firms Working Flat Out On COVID-19 Tests, As Govt Promises Test Capacity Increase

Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients

Topics

UsernamePublicRestriction

Register

PS099157

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel